WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $13.15 and last traded at $13.03, with a volume of 1941 shares changing hands. The stock had previously closed at $12.91.
WuXi Biologics (Cayman) Stock Performance
The company’s 50-day moving average is $9.92 and its 200-day moving average is $9.30.
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.
The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.
Recommended Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- Berkshire Boosts Its Bet: This AI Hyperscaler Is Now a Top-3 Holding
- NVIDIA Reveals $21 Billion SpaceX Stake: Signal of Confidence or Circular Financing?
- NVIDIA Earnings Could Move These 3 AI Stocks—Here’s What to Watch
- XPeng’s Top Secret AI Robotics Program Outshines EV Woes
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
